Session Purpose:
To provide practical insights into the interpretation and clinical relevance of key breast cancer immunohistochemistry (IHC) markers.

Key Objectives:
1. Review major IHC markers used in breast cancer diagnosis and prognosis.
2. Explain interpretation of marker expression patterns.
3. Highlight the role of IHC results in guiding patient management.

Speaker: Ms. Christine Osale- MLO, MSc., BSc., MLS – Deputy In-charge, Histopathology/Cytology Lab – KNH

Moderator: Ms. Susan Kiambi—Maabara Online

CPD Points: This event is worth 3 CPD points

N/B:

i) The minimum duration for participation to qualify for CPD points is 60%.

ii) Use the same email address used during registration to join the meeting.

iii) Ensure the details used during registration are correct.

iv) Your CPD points will be uploaded on your KMLTTB CPD portals after the event and within 24 hours.

v) Registration closes at 7:45 PM before the next event.